First Report on the Moroccan Registry of Primary Immunodeficiencies: 15 Years of Experience (1998–2012)
Authors:
- For The Moroccan Society For Primary Immunodeficiencies (Mspid)F(For The Moroccan Society For Primary Immunodeficiencies (Mspid)
- A. A. BousfihaABA. A. Bousfiha
- 12 March 2014
- journal article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 34 (4) , 459-468
Abstract
Primary immunodeficiencies (PIDs) are a large group of diseases characterized by susceptibility to infections. We provide the first comprehensive report on PIDs in Morocco, the epidemiological, clinical, etiological and outcome features which have never before been described. A national registry was established in 2008, grouping together data for PID patients diagnosed since 1998. In total, 421 patients were diagnosed between 1998 and 2012. Parental consanguinity was common (recorded for 43.2 % of patients) and the median time to diagnosis was 2.0 years. Overall, 27.4 % of patients were considered to have well defined syndromes with immunodeficiency (48 cases of hyper-IgE syndrome and 40 of ataxia-telangiectasia); 22.7 % had predominantly antibody deficiencies (29 cases of agammaglobulinemia and 24 of CVID); 20.6 % had combined immunodeficiencies (37 cases of SCID and 26 of MHC II deficiencies) and 17.5 % had phagocyte disorders (14 cases of SCN and 10 of CGD). The principal clinical signs were lower respiratory tract infections (60.8 %), skin infections (33.5 %) and candidiasis (26.1 %). Mortality reached 28.8 %, and only ten patients underwent bone marrow transplantation. We analyzed the impact on mortality of residence, family history, parental consanguinity, date of diagnosis and time to diagnosis, but only date of diagnosis had a significant effect. The observed prevalence of PID was 0.81/100,000 inhabitants, suggesting considerable underdiagnosis and a need to increase awareness of these conditions in Morocco. The distribution of PIDs was different from that reported in Western countries, with a particularly high proportion of SCID, MHC II deficiencies, hyper-IgE syndrome and autosomal recessive agammaglobulinemia. However, we have now organized a national network, which should improve diagnosis rates in remote regions.Keywords
This publication has 24 references indexed in Scilit:
- Molecular Defects in Moroccan Patients with Ataxia-TelangiectasiaNeuroMolecular Medicine, 2013
- Primary immunodeficiencies in highly consanguineous North African populationsAnnals of the New York Academy of Sciences, 2011
- Major histocompatibility complex class II expression deficiency caused by a RFXANK founder mutation: a survey of 35 patientsBlood, 2011
- Primary Immunodeficiency Diseases: An Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary ImmunodeficiencyFrontiers in Immunology, 2011
- The French national registry of primary immunodeficiency diseasesClinical Immunology, 2010
- The 752delG26 mutation in the RFXANK gene associated with major histocompatibility complex class II deficiency: evidence for a founder effect in the Moroccan populationEuropean Journal of Pediatrics, 2010
- Simultaneous presentation of 2 rare hereditary immunodeficiencies: IL-12 receptor β1 deficiency and ataxia-telangiectasiaJournal of Allergy and Clinical Immunology, 2008
- Intermittent chronic neutropenia in a patient with familial Mediterranean feverPediatric Blood & Cancer, 2008
- Interleukin‐12 Receptor β1 Deficiency in a Patient with Abdominal TuberculosisThe Journal of Infectious Diseases, 2001
- Les déficits immunitaires primitifs en Tunisie: étude de 152 casArchives de Pédiatrie, 1997